DNA Methylation-Based Epigenetic Age Mediates Link Between LE8 Score, CVD
By Elana Gotkine HealthDay Reporter
WEDNESDAY, May 29, 2024 -- The associations between Life's Essential 8 (LE8) and cardiovascular health are mediated by DNA methylation-based epigenetic age, according to a study published online May 29 in the Journal of the American Heart Association.
Madeleine Carbonneau, from the National Institutes of Health in Bethesda, Maryland, and colleagues calculated LE8 scores for 5,682 participants from the Framingham Heart Study. Four DNA methylation-based epigenetic age biomarkers were implemented and whether these biomarkers mediated the associations between the LE8 score and cardiovascular disease (CVD), CVD-specific mortality, and all-cause mortality was examined.
The researchers observed an association for a one standard deviation increase in the LE8 score with a 35, 36, and 29 percent lower risk of incident CVD, CVD-specific mortality, and all-cause mortality, respectively. Epigenetic age markers partly mediated these association, especially the GrimAge and DunedinPACE scores. Compared to those with lower genetic risk, those with higher genetic risk for older epigenetic age tended to have more profound potential mediation effects by epigenetic age biomarkers. For example, the mean proportion of mediation was 39, 39, and 78 percent for the association of the LE8 score with incident CVD, CVD-specific mortality, and all-cause mortality, respectively, in participants with higher GrimAge polygenic scores.
"Our data suggest that, in individuals with higher genetic predisposition for older epigenetic age scores, an optimal cardiovascular health may be beneficial by decreasing their epigenetic burden," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
342 Cardiology Clinics Acquired by Private Equity Firms in 2013 to 2023
WEDNESDAY, July 3, 2024 -- From 2013 to 2023, 342 cardiology clinics were acquired by private equity firms, with 94.7 percent of the acquisitions occurring between 2021 and 2023...
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.